Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma
ClinicalTrials.gov study NCT05563012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment
ClinicalTrials.gov study NCT03978611. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Clinical Study of Mitoxantrone Hydrochloride Liposome Combined with PD-1 Blockade in Recurrent or Metastatic NPC
ClinicalTrials.gov study NCT06472713. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
ClinicalTrials.gov study NCT06549855. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
ClinicalTrials.gov study NCT06561308. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors
ClinicalTrials.gov study NCT04276376. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label Study on the Clinical Efficacy of rTMS Intervention in PD
ClinicalTrials.gov study NCT06542991. IPD Sharing: NO. Countries: 1. Publications: 0.
This is a Study to Evaluate the Safety, Tolerability, PK and PD of IV Administered ABL301 in Healthy Adult Participants
ClinicalTrials.gov study NCT05756920. IPD Sharing: NO. Countries: 1. Publications: 0.
Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%
ClinicalTrials.gov study NCT03808480. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I, Double-Blind,Placebo, MAD Study to Evaluate the Safety, Tolerability, PK, and PD of AMG 333 in Healthy Subjects and Migraine Subjects
ClinicalTrials.gov study NCT02132429. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-1 Antibody for Reactive EBV After BMT
ClinicalTrials.gov study NCT04690036. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-L1 PET-imaging During CAR T-cell Therapy
ClinicalTrials.gov study NCT05404048. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies
ClinicalTrials.gov study NCT01522989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects
ClinicalTrials.gov study NCT04079062. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 MAb, Administered Alone and in Combination with a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
ClinicalTrials.gov study NCT05431270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
ClinicalTrials.gov study NCT05738694. IPD Sharing: NO. Countries: 1. Publications: 0.
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
ClinicalTrials.gov study NCT05339581. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Chemotherapy on PD-L1 in NSCLC
ClinicalTrials.gov study NCT03701607. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07138209. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Mindfulness Meditation (MBSR) and Parkinson's Disease (PD)
ClinicalTrials.gov study NCT05180643. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.